Endocrinology and Diabetes Management Best Practices

01Purpose and scope

This manual supports the course Endocrinology and Diabetes Management. It describes how clinicians, nurses, pharmacists and diabetes educators work through the care of people with diabetes and common hormone disorders, including thyroid disease, adrenal conditions, pituitary problems and bone and calcium disorders that appear in endocrine clinics.
The scope covers outpatient and primary care settings where most day-to-day decisions happen, along with the handoffs to hospital teams when a patient is admitted with a hyperglycemic crisis or a severe hypoglycemic event. It does not replace specialty training in endocrinology, and it does not cover pediatric or pregnancy-specific protocols in depth, which have their own guidance and referral pathways.
This guidance does not replace qualified professional judgment, approved local procedures or required prescribing authorization. Medication choices, dose changes and diagnostic decisions belong to licensed staff working within their scope of practice and their organization's formulary and protocols.

02Core principles

Individualize every target. Glycemic goals, blood pressure goals and lipid goals depend on age, comorbidities, hypoglycemia risk, life expectancy, cognition and what the patient can realistically do at home. A target that suits a healthy adult with a new diagnosis may be unsafe for an older adult who lives alone and takes a sulfonylurea.
Treat the cause as well as the number. A high HbA1c or an abnormal thyroid-stimulating hormone result is a signal to look at adherence, diet, sleep, infection, steroid use, kidney function and medication timing before adding another drug.
Prefer the least complex plan that meets the goal. Each new medication adds cost, monitoring burden and interaction risk. Simplifying a regimen is often a clinical improvement, not a compromise.
Make hypoglycemia prevention a standing concern. Any intervention that lowers glucose, especially insulin or sulfonylureas, needs a plan for what the patient will do when intake drops, exercise increases or illness begins.
Shared decision making is the working method, not an add-on. The patient's values, daily routine, cost limits and confidence with self-management determine whether a plan will hold.

03Planning and preparation

Before a visit, review the most recent HbA1c, fasting and random glucose values, home glucose logs or continuous glucose monitoring reports, renal function, potassium, lipid results, thyroid tests if relevant, and any hospital discharge summaries from the past several months. Confirm the current medication list with the patient and the pharmacy, because discrepancies are common when several prescribers are involved.
Identify the decision the visit must make. A follow-up for a patient starting a basal insulin needs a different preparation than a visit to evaluate fatigue, weight change and suspected hypothyroidism. Write the decision at the top of the note so the visit stays focused.
Gather tools and materials in advance: a glucometer or access to CGM data, insulin pen needles or pump supplies if used, a glucagon product that is in date and approved locally, sick day guidance sheets, and a blood pressure cuff. Check whether the clinic has a validated fall risk or depression screen that is appropriate for the patient.
Confirm the patient's coverage and access. Prior authorization, pharmacy stock and out-of-pocket cost can decide whether a plan is realistic. A care team that learns about a denied prescription two weeks later has lost time that a quick call could have saved.

04Recommended workflow

1
: Establish the diagnosis and its basis. Confirm that the diagnosis matches the criteria used locally, such as HbA1c, fasting glucose, oral glucose tolerance testing or random glucose with symptoms. For thyroid, adrenal and pituitary problems, document the pretest suspicion and the confirmatory test rather than relying on a single abnormal value.
2
: Characterize the condition. For diabetes, record type, duration, insulin deficiency signs, prior episodes of diabetic ketoacidosis or severe hypoglycemia, and complications including retinopathy, nephropathy, neuropathy and cardiovascular disease. For hormone disorders, note symptoms, medication effects, pregnancy status and results of imaging when ordered.
3
: Set individualized goals with the patient. Write the glycemic target, the acceptable hypoglycemia risk and the timeframe for reassessment. Record what the patient considers success, since it is often different from the number on the lab report.
4
: Choose the initial or revised therapy. For type 2 diabetes, the choice of agent often depends on established cardiovascular or kidney disease, weight goals, hypoglycemia risk and cost. For hypothyroidism, levothyroxine dosing and timing are usually adjusted from the most recent thyroid-stimulating hormone, with attention to absorption interactions such as calcium, iron and proton pump inhibitors. Check current labeling and local guidance for doses and contraindications.
5
: Teach the regimen and confirm understanding. Use teach-back, asking the patient to explain how they will take the medication, what they will do if a dose is missed and what symptoms of low glucose look like. Check the injection technique or meter use at the visit when possible.
6
: Arrange monitoring and follow-up. Specify when labs will be repeated, who reviews glucose data and how the patient should contact the clinic between visits. Good instructions name the threshold values that trigger a call rather than saying only to call if worried.
7
: Document and hand off. Record the decision, the rationale, the patient's agreement and the next review date. Send the plan to pharmacy, the patient's other prescribers and any diabetes educator or dietitian involved.

05Quality checks, risk controls and compliance

Use a short set of safety checks at every medication change. Confirm renal function before starting metformin or adjusting doses of drugs cleared by the kidney. Review the risk of hypoglycemia with insulin or sulfonylureas and ensure glucagon or a fast-acting carbohydrate source is available. Check for interactions with corticosteroids, beta blockers that may mask hypoglycemia symptoms, and drugs that alter thyroid hormone absorption.
Hypoglycemia management should follow a written protocol. A common approach for conscious patients is the rule of fifteen: take about 15 grams of fast-acting carbohydrate, recheck glucose after 15 minutes and repeat if it remains low. Unconscious or unable to swallow patients need glucagon or emergency services according to local protocol. Patients who have had a severe episode may need a review of their target and regimen the same week.
Sick day rules protect against ketoacidosis and dehydration. Patients on sodium-glucose cotransporter 2 inhibitors need guidance about ketone risk and temporary holds during acute illness or before procedures, as set by current labeling and the prescribing team. Patients on insulin need instructions to continue basal insulin during illness and to check ketones when glucose is persistently high.
Compliance depends on where you practice. Privacy rules, controlled substance handling, reporting requirements for certain conditions, driving guidance for people with hypoglycemia, and coverage criteria for devices and drugs vary by jurisdiction and payer. Check the current authoritative source in your region and your organization's policy manual rather than relying on memory or this summary.
Published standards are useful reference points. The American Diabetes Association Standards of Care are widely used in the United States and are updated regularly, so confirm you are reading the current edition. Local endocrine society guidance and national formularies may differ, and the stricter local requirement generally applies.

06Collaboration and documentation

Diabetes care is team work. Diabetes educators handle injection training, meter use and meal planning. Dietitians adjust eating plans to match medications and personal preferences. Pharmacists check interactions, prepare dose charts and address adherence barriers. Social workers and case managers help with cost, transport and home support. Name the person responsible for each element of the plan so nothing depends on an assumption.
Documentation should let another clinician continue care without calling you. Record the diagnosis, current regimen with doses and timing, the most recent results with dates, the individualized targets, hypoglycemia history, the patient's self-management ability and the next steps. Avoid writing only that the patient was counseled; state what was taught and how understanding was checked.
Share goals with the patient in plain language and provide a written copy of changes. For insulin users, a dose table that lists the basal dose, correction scale if used, and when to call is more useful than a long narrative. Keep the list current and ask the patient to bring meters, pens and pump devices to visits when possible.

07Measures and continuous improvement

Track a small set of indicators that reflect real outcomes. Useful measures include the proportion of patients with HbA1c results in the past six months, the share with a documented individualized target, the number of severe hypoglycemic events, the rate of diabetic ketoacidosis admissions, the percentage with an annual eye and foot exam recorded, and the proportion who have a documented plan for sick days. Choose measures your clinic can collect without heavy manual abstraction.
Review data in regular huddles. A monthly look at a panel of patients on insulin may reveal a pattern, such as several patients with unexplained lows after a formulary change. Treat these reviews as learning, not blame, and look at system causes first, including refill timing, supply shortages and staff turnover.
Be aware of trade-offs in measurement. A strict HbA1c target can improve one number while increasing hypoglycemia. Glucose-lowering drugs that suit one patient may be poor choices for another. Continuous glucose monitoring improves visibility of patterns but produces large volumes of data that need a clear review process. Measures should prompt better decisions, not simply fill dashboards.

08Common mistakes and how to prevent them

Relying on a single HbA1c value to change therapy. HbA1c can be affected by anemia, kidney disease, hemoglobin variants and recent transfusion. Pair it with glucose logs or CGM data and ask whether the number matches what the patient experiences.
Adding medication before checking adherence and technique. Many apparent treatment failures come from missed doses, expired insulin, incorrect pen priming or meter errors. Ask the patient to show you the process before escalating therapy.
Starting a sulfonylurea or insulin without a hypoglycemia plan. Prevent this by writing the rescue steps, confirming the patient has fast-acting carbohydrate at home and checking whether driving or work safety is affected.
Missing the effect of other drugs on endocrine results. Corticosteroids raise glucose, biotin supplements can distort some immunoassay results, and certain medications change thyroid hormone absorption. Review the full medication list at each visit.
Letting sick day guidance stay in the chart. Give patients a written sheet at the time of starting a relevant drug, and review it during each annual or periodic visit so it stays in memory.

09Practical checklist

Confirm the diagnosis with the criteria and tests used in your setting and record the basis.
Review the most recent labs, glucose data and medication list, including pharmacy fill history.
Set an individualized glycemic or hormonal target with the patient and write it in the note.
Assess hypoglycemia risk and confirm the patient has fast-acting carbohydrate and glucagon if prescribed.
Check renal and hepatic function before starting or adjusting renally cleared drugs.
Verify the patient can demonstrate injection, meter or device use, using teach-back.
Provide written sick day rules and threshold values that prompt a call to the clinic.
Confirm coverage, prior authorization and pharmacy stock before the patient leaves.
Schedule the next lab check and follow-up with a named clinician responsible for reviewing results.
Send the updated plan to pharmacy, the diabetes educator and any other prescribers involved.

★Learning sources

Micro Degree: Endocrinology and Diabetes Management
Micro Degree: Healthcare Administration Practice
Micro Degree: Physiotherapy Assistant Operations
Micro Degree: Cardiac Care Support

?Frequently asked questions

How often should HbA1c be checked in a patient with diabetes?

Many clinicians check HbA1c about every three to six months, with the interval depending on whether the regimen changed recently and whether the result is at target. Confirm the current interval in the most recent standards your organization follows. Use glucose logs or CGM data between HbA1c checks, since HbA1c reflects an average and can miss short episodes of low or high glucose.

What should I do if a patient on insulin has a low glucose reading at home?

For a conscious patient, follow the local protocol, which commonly includes about 15 grams of fast-acting carbohydrate, a recheck after 15 minutes and repeat treatment if still low. Review the dose, meal timing and activity that preceded the episode, and consider whether the target or regimen needs adjustment. Any severe episode requiring assistance should prompt same-week review by the prescribing clinician.

Does this manual tell me which medication to prescribe?

No. This guidance describes how decisions are typically organized, but it does not replace qualified professional judgment, approved procedures or required prescribing authorization. Check current product labeling, your formulary, and the authoritative guidance applicable in your jurisdiction before starting, stopping or changing any medication.